Synthesis of â-Fluoro-R,â-unsaturated Esters
J . Org. Chem., Vol. 65, No. 3, 2000 699
Eth yl 3-P h en yl-3-flu or o-2-p r op en oa te (4a ). (E)-Isom er :
1H NMR (CD3COCD3) δ 7.78-7.49 (5H, m), 5.93 (1H, d, J )
7.83 (2H, d, J ) 8.4 Hz), 6.02 (1H, d, J ) 20.4 Hz), 4.14 (2H,
q, J ) 7.1 Hz), 2.63 (3H, s), 1.17 (3H, t, J ) 7.1 Hz); 19F NMR
(CCl4) δ 3.6 (d, J ) 20.4 Hz); MS (m/z) 236 (M+, 34.97), 221
20.8 Hz), 4.12 (2H, q, J ) 7.0 Hz), 1.18 (3H, t, J ) 7.0 Hz); 19
F
NMR (CCl4) δ 0.3 (d, J ) 20.8 Hz); MS (m/z) 194 (M+, 18.21),
(100.00); IR (cm-1) 1725, 1690, 1661. Anal. Calcd for C13H13
-
149 (100.00); IR (cm-1) 1726, 1659. Anal. Calcd for C11H11
-
FO3: C, 66.10; H, 5.51. Found: C, 65.95; H, 5.70. (Z)-
Isom er : 1H NMR (CD3COCD3) δ 8.09 (2H, d, J ) 8.4 Hz),
7.92 (2H, d, J ) 8.4 Hz), 6.26 (1H, d, J ) 34.3 Hz), 4.20 (2H,
q, J ) 7.1 Hz), 2.63 (3H, S), 1.27 (3H, t, J ) 7.2 Hz); 19F NMR
(CCl4) δ 21.6 (d, J ) 34.3 Hz); MS (m/z) 236 (M+, 28.78), 221
(100.00).
FO2: C, 68.04; H, 5.67; F, 9.79. Found: C, 68.33; H, 5.83; F,
9.80. (Z)-Isom er : 1H NMR (CD3COCD3) δ 7.81-7.78 (2H, m),
7.58-7.53 (3H, m), 6.12 (1H, d, J ) 34.4 Hz), 4.21 (2H, q, J )
7.0 Hz), 1.29 (3H, t, J ) 7.0 Hz); 19F NMR (CCl4) δ 17.6 (d, J
) 34.4 Hz); MS (m/z) 194 (M+, 20.24), 149 (100.00).
(E)-Eth yl 3-(4-br om oph en yl)-3-flu or o-2-pr open oate (4b):
1H NMR (CD3COCD3) δ 7.70 (4H, s), 5.99 (1H, d, J ) 20.8
Hz), 4.11 (2H, q, J ) 7.0 Hz), 1.18 (3H, t, J ) 7.0 Hz); 19F
NMR (CCl4) δ 1.3 (d, J ) 20.8 Hz); MS (m/z) 273 (M+, 4.86),
Eth yl 3-(4-Hyd r oxyp h en yl)-3-flu or o-2-p r op en oa te (4j).
(E)-Isom er : 1H NMR (CD3COCD3) δ 7.65 (2H, d, J ) 9.5 Hz),
6.90 (2H, d, J ) 9.5 Hz), 5.73 (1H, d, J ) 22.1 Hz), 4.10 (2H,
q, J ) 7.1 Hz), 1.19 (3H, t, J ) 7.1 Hz); 19F NMR (CCl4) δ 3.0
(d, J ) 22.1 Hz); MS (m/z) 211 (M+ + 1, 24.15), 210 ((M+,
43.48), 165 (100.00); IR (cm-1) 3388, 1699, 1652. Anal. Calcd
for C11H11FO3: C, 62.86; H, 5.24; F, 9.05. Found: C, 62.77; H,
5.49; F, 8.86. (Z)-Isom er : 1H NMR (CD3COCD3) δ 7.63 (2H,
d, J ) 8.8 Hz), 6.98 (2H, d, J ) 8.8 Hz), 5.89 (1H, d, J ) 34.8
Hz), 4.15 (2H, q, J ) 7.1 Hz), 1.24 (3H, t, J ) 7.1 Hz); 19F
NMR (CCl4) δ 17.0 (d, J ) 34.8 Hz); MS (m/z) 210 ((M+, 40.89),
165 (100.00).
227 (100.00); IR (cm-1) 1728, 1656; HRMS calcd for C11H10
Br79FO2: 271.9849, found: 271.9847.
-
Eth yl 3-(4-Nitr oph en yl)-3-flu or o-2-pr open oate (4c). (E)-
Isom er : 1H NMR (CD3COCD3) δ 8.34 (2H, d, J ) 8.3 Hz), 8.00
(2H, d, J ) 8.4 Hz), 6.12 (1H, d, J ) 20.2 Hz), 4.12 (2H, q, J
) 7.0 Hz), 1.17 (3H, t, J ) 7.0 Hz); 19F NMR (CCl4) δ 1.6 (d, J
) 20.2 Hz); MS (m/z) 240 (M++1, 0.68), 239 (M+, 2.92), 194
(100.00); IR (cm-1) 1724, 1664. Anal. Calcd for C11H10FNO4:
C, 55.23; H, 4.18; N, 5.86. Found: C, 55.44; H, 4.24; N, 5.80.
(Z)-Isom er : 1H NMR (CCl4) δ 8.27 (2H, d, J ) 8.0 Hz), 7.84
(2H, d, J ) 8.0 Hz), 5.93 (1H, d, J ) 33.0 Hz), 4.23 (2H, q, J
) 7.0 Hz), 1.37 (3H, t, J ) 7.0 Hz); 19F NMR (CCl4) δ 19.0 (d,
J ) 33.0 Hz); MS (m/z) 240 (M+ + 1, 7.03), 239 (M+, 36.10),
194 (100.00).
Eth yl 3-(4-Ch or op h en yl)-3-flu or o-2-p r op en oa te (4k ):
1H NMR (CD3COCD3) δ 7.78 (2H, d, J ) 8.5 Hz), 7.54 (2H, d,
J ) 8.7 Hz), 5.97 (1H, d, J ) 20.7 Hz), 4.12 (2H, q, J ) 7.1
Hz), 1.19 (3H, t, J ) 7.1 Hz); 19F NMR (CCl4) δ 3.67 (d, J )
20.7 Hz); MS (m/z) 228 (M+, 36.43), 183 (100.00); IR (cm-1
)
1726, 1659; HRMS calcd for C11H10FCl35O2: 228.0354, found:
228.0336.
(E)-E t h yl
3-(3-n it r op h en yl)-3-flu or o-2-p r op en oa t e
(4d ): 1H NMR (CD3COCD3) δ 8.62 (1H, s), 8.43-8.40 (1H, m),
8.17-8.14 (1H, m), 7.83 (1H, t, J ) 8.4 Hz), 6.11 (1H, d, J )
(E)-Eth yl 3-(2-n a p h th yl)-3-flu or o-2-p r op en oa te (4l): 1H
NMR (CD3COCD3) δ 8.11-7.92 (3H, m,), 7.69-7.56 (4H, m),
6.22 (1H, d, J ) 17.1 Hz), 3.90 (2H, q, J ) 7.1 Hz), 0.92 (3H,
t, J ) 7.1 Hz); 19F NMR (CCl4) δ -7.7 (d, J ) 17.1 Hz); MS
(m/z) 244 (M+, 55.81), 171 (100.00); IR (cm-1) 1728, 1667. Anal.
Calcd for C15H13FO2: C, 73.77; H, 5.33. Found: C, 73.78; H,
5.43.
20.3 Hz), 4.13 (2H, q, J ) 7.0 Hz), 1.18 (3H, t, J ) 7.0 Hz); 19
F
NMR (CCl4) δ 2.3 (d, J ) 20.3 Hz); MS (m/z) 239 (M+, 2.85),
194 (100.00); IR (cm-1) 1724, 1662. Anal. Calcd for C11H10
-
FNO4: C, 55.23; H, 4.18; N, 5.86. Found: C, 55.02; H, 4.21;
N, 5.84.
Eth yl 3-(4-Meth oxyp h en yl)-3-flu or o-2-p r op en oa te (4e).
(E)-Isom er : 1H NMR (CCl4) δ 7.80 (2H, d, J ) 9.0 Hz), 6.90
(2H, d, J ) 9.0 Hz), 5.73 (1H, d, J ) 21.0 Hz), 4.13 (2H, q, J
) 7.0 Hz), 3.86 (3H, s), 1.30 (3H, t, J ) 7.0 Hz); 19F NMR (CCl4)
δ 0.7 (d, J ) 21.0 Hz); MS (m/z) 224 (M+, 62.01), 179 (100.00);
IR (cm-1) 1723, 1630. Anal. Calcd for C12H13FO3: C, 64.29; H,
5.80. Found: C, 64.40; H, 5.79. (Z)-Isom er : 1H NMR (CCl4)
δ 7.5 (2H, d, J ) 9.0 Hz), 6.8 (2H, d, J ) 9.0 Hz), 5.62 (1H, d,
J ) 33.0 Hz), 4.1 (2H, q, J ) 7.0 Hz), 3.8 (3H, s), 1.3 (3H, t, J
) 7.0 Hz); 19F NMR (CCl4) δ 17.6 (d, J ) 33.0 Hz).
(E)-Eth yl 3-(2-m eth oxyp h en yl)-3-flu or o-2-p r op en oa te
(4f): 1H NMR (CD3COCD3) δ 7.51-7.45 (1H, m), 7.38-7.34
(1H, m), 7.10 (1H, d, J ) 8.5 Hz), 7.04-6.98 (1H, m), 5.90 (1H,
d, J ) 17.0 Hz), 4.00 (2H, q, J ) 7.1 Hz), 3.85 (3H, s), 1.07
(3H, t, J ) 7.1 Hz); 19F NMR (CCl4) δ -3.7 (d, J ) 17.0 Hz);
MS (m/z) 224 (M+, 24.61), 193 (100.00); IR (cm-1) 1729, 1670.
Anal. Calcd for C12H13FO3: C, 64.29; H, 5.80. Found: C, 63.90;
H, 5.90.
(E)-E t h yl
3-(2-t h iop h en e-yl)-3-flu or o-2-p r op en oa t e
(4m ): 1H NMR (CD3COCD3) δ 8.09 (1H, d, J ) 3.8 Hz), 7.90-
7.88 (1H, m), 7.25-7.21 (1H, m), 5.83 (1H, d, J ) 24.2 Hz),
4.20 (2H, q, J ) 7.1 Hz), 1.26 (3H, t, J ) 7.2 Hz); 19F NMR
(CCl4) δ 3.3 (d, J ) 24.2 Hz); MS (m/z) 201 (M+, 9.19), 200
(M+-1, 55.33), 155 (100.00); IR (cm-1) 1716, 1634. Anal. Calcd
for C9H10FSO2: C, 53.73; H, 4.98. Found: C, 54.00; H, 4.62.
Eth yl 3-Flu or o-5-(tr im eth ylsilyl)pen ta-2,4-dien oate (4n ).
(2E)-Isom er : 1H NMR (CD3COCD3) δ 7.57 (1H, d-d, J ) 27.2,
19.2 Hz), 6.77 (1H, d, J ) 18.7 Hz), 5.63 (1H, d, J ) 19.2 Hz),
4.17 (2H, q, J ) 7.1 Hz), 1.25 (3H, t, J ) 7.1 Hz), 0.0 (9H,s);
19F NMR (CCl4) δ 23.0 (d-d, J ) 27.2, 18.7 Hz); MS (m/z) 217
(M+ + 1, 20.30), 77 (100.00); IR (cm-1) 1720, 1645. Anal. Calcd
for C10H17FO5Si: C, 55.56; H, 7.87. Found: C, 55.55; H, 8.06.
(2Z)-Isom er : 1H NMR (CD3COCD3) δ 6.72 (1H, d, J ) 18.9
Hz), 6.53 (1H, d-d, J ) 22.4, 18.9 Hz), 5.58 (1H, d, J ) 32.8
Hz), 4.14 (2H, q, J ) 7.1 Hz), 1.27 (3H, t, J ) 7.1 Hz), 0.0 (9H,
s); 19F NMR (CCl4) δ 24.0 (ddd, J ) 32.8, 22.4, 3.5 Hz); MS
(m/z) 217 (M+ + 1, 10.68), 77 (100.00).
(2E)-Dieth yl 3-flu or oh exa-2,4-dien edioate (4o): 1H NMR
(CD3COCD3) δ 8.18 (1H, dd, J ) 29.1, 15.9 Hz), 6.47 (1H, d-d,
J ) 15.9, 0.5 Hz), 5.97 (1H, d-d, J ) 18.0, 0.4 Hz), 4.26 (2H,
q, J ) 6.8 Hz), 4.19 (2H, q, J ) 7.1 Hz), 1.30 (3H, t, J ) 7.2
Hz), 1.27 (3H, t, J ) 6.8 Hz); 19F NMR (CCl4) δ 25.6 (d-d, J )
29.0, 18.0 Hz); MS (m/z) 217 (M++1, 10.40), 143 (100.00); IR
(cm-1) 1724, 1657. Anal. Calcd for C10H13FO4: C, 55.56; H,
6.02. Found: C, 55.80; H, 6.22.
Meth yl 4-(2-(Eth oxyca r bon yl)-1-flu or o-1-eth en yl)ben -
zoa te (4g). (E)-Isom er : 1H NMR (CD3COCD3) δ 8.09 (2H, d,
J ) 8.3 Hz), 7.84 (2H, d, J ) 8.3 Hz), 6.03 (1H, d, J ) 20.6
Hz), 4.12 (2H, q, J ) 7.1 Hz), 3.91 (3H, s), 1.17 (3H, t, J ) 7.1
Hz); 19F NMR (CCl4) δ 0.6 (d, J ) 20.6 Hz); MS (m/z) 252 (M+,
24.44), 207 (100); IR (cm-1) 1728, 1649. Anal. Calcd for C13H13
-
FO4: C, 61.90; H, 5.16. Found: C, 61.76; H, 5.28. (Z)-
Isom er : 1H NMR (CCl4) δ 7.90 (2H, d, J ) 9.0 Hz), 7.60 (2H,
d, J ) 9.0 Hz), 5.80 (1H, d, J ) 33.0 Hz), 4.16 (2H, q, J ) 7.0
Hz), 3.86 (3H, S), 1.26 (3H, t, J ) 7.0 Hz); 19F NMR (CCl4) δ
18.3 (d, J ) 33.0 Hz); MS (m/z) 252 (M+, 21.27), 207 (100.00).
(E)-Meth yl 2-(2-(eth oxyca r bon yl)-1-flu or o-1-eth en yl)-
ben zoa te (4h ): 1H NMR (CD3COCD3) δ 8.05-8.03 (1H, m),
771-7.65 (2H, m), 7.57-7.54 (1H, m), 5.91 (1H, d, J ) 17.2
Hz), 3.95 (2H, q, J ) 7.1 Hz), 3.85 (3H, s), 1.03 (3H, t, J ) 7.2
Hz); 19F NMR (CCl4) δ -10.0 (d, J ) 17.2 Hz); MS (m/z) 252
(M+, 1.13), 179 (100.00); IR (cm-1) 1730, 1674. Anal. Calcd for
(E)-Eth yl 3-(1,3-d im eth yl-2,4-d ioxo-1,2,3,4-tetr a h yd r o-
p yr im id in -5-yl)-3-flu or o-2-p r op en oa te (4p ): 1H NMR (CD3-
COCD3) δ 8.07 (1H, s), 5.86 (1H, d, J ) 16.4 Hz), 4.09 (2H, q,
J ) 7.1 Hz), 3.50 (3H, s), 3.27 (3H, s), 1.19 (3H, t, J ) 7.1 Hz);
19F NMR (CCl4) δ 2.0 (d, J ) 16.4 Hz); MS (m/z) 256 (M+,
15.92), 184 (100.00); IR (cm-1) 1716, 1674; HRMS calcd for
C11H13FN2O4: 256.0860, found: 256.0848.
C
13H13FO4: C, 61.90; H, 5.16. Found: C, 61.69; H, 5.28.
Eth yl 3-(4-Acetylp h en yl)-3-flu or o-2-p r op en oa te (4i).
(E)-3,5-Di-O-b en zoyl-5-[1-flu or o-2-(et h oxyca r b on yl)-
eth en yl]-2-d eoxyu r id in e (4q): R20D -69.3° (c ) 0.9, CHCl3);
1H NMR (CDCl3) δ 8.08-7.97 (5H, m), 7.66-7.42 (6H, m),
(E)-Isom er : 1H NMR (CD3COCD3) δ 8.06 (2H, d, J ) 8.4 Hz),